Profil
Maud Brandely worked as the Director of Oncology Clinical Development at Pierre Fabre SA and as the Director of Taxotere Clinical Development at Rhone-Poulenc SA. From 2016 to 2024, Dr. Brandely served as the Chief Medical Officer & VP of Medical Affairs at Transgene SA. Dr. Brandely obtained a graduate and doctorate degree from Université Pierre et Marie Curie.
Ehemalige bekannte Positionen von Maud Brandely
| Unternehmen | Position | Ende |
|---|---|---|
| TRANSGENE | Technik-/Wissenschafts-/F&E-Leiter | 10.09.2024 |
Pierre Fabre SA
Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Corporate Officer/Principal | 01.02.2016 |
Rhone-Poulenc SA
Rhone-Poulenc SA Chemicals: SpecialtyProcess Industries Manufactures and supplies chemicals | Corporate Officer/Principal | - |
Ausbildung von Maud Brandely
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Pierre Fabre SA
Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Health Technology |
Rhone-Poulenc SA
Rhone-Poulenc SA Chemicals: SpecialtyProcess Industries Manufactures and supplies chemicals | Process Industries |
Université Pierre et Marie Curie
Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















